SharePost Content Read More Yahoo Finance #finance Post navigation Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny ImmunityBio, Inc. (IBRX) Price Target Raised After Strong ANKTIVA Launch